Sileo A, Sassun R, Ng J, Aboelmaaty S, Gomaa I, Mari G
Ann Surg Oncol. 2025; 32(4):2302-2307.
PMID: 39789280
DOI: 10.1245/s10434-024-16773-w.
Coco C, Rizzo G, Amodio L, Pafundi D, Marzi F, Tondolo V
Cancers (Basel). 2024; 16(23).
PMID: 39682094
PMC: 11640487.
DOI: 10.3390/cancers16233906.
Grillo F, Ali M, Paudice M, Pigozzi S, Anselmi G, Scabini S
Virchows Arch. 2023; 483(5):677-685.
PMID: 37773452
PMC: 10673985.
DOI: 10.1007/s00428-023-03661-z.
Nolano A, Rossi G, DAngelo V, Liccardo R, De Rosa M, Izzo P
Int J Mol Sci. 2023; 24(6).
PMID: 36983044
PMC: 10051096.
DOI: 10.3390/ijms24065970.
Cavestro G, Mannucci A, Balaguer F, Hampel H, Kupfer S, Repici A
Clin Gastroenterol Hepatol. 2022; 21(3):581-603.e33.
PMID: 36549470
PMC: 11207185.
DOI: 10.1016/j.cgh.2022.12.006.
HLA-G as a prognostic marker in stage II/III colorectal cancer: not quite there yet.
Gambella A, Scabini S, Zoppoli G, De Silvestri A, Pigozzi S, Paudice M
Histochem Cell Biol. 2022; 158(6):535-543.
PMID: 35902421
PMC: 9726768.
DOI: 10.1007/s00418-022-02141-w.
The histomorphological and molecular landscape of colorectal adenomas and serrated lesions.
Galuppini F, Fassan M, Mastracci L, Gafa R, Lo Mele M, Lazzi S
Pathologica. 2021; 113(3):218-229.
PMID: 34294939
PMC: 8299322.
DOI: 10.32074/1591-951X-270.
From Genetics to Histomolecular Characterization: An Insight into Colorectal Carcinogenesis in Lynch Syndrome.
Lepore Signorile M, Disciglio V, Di Carlo G, Pisani A, Simone C, Ingravallo G
Int J Mol Sci. 2021; 22(13).
PMID: 34201893
PMC: 8268977.
DOI: 10.3390/ijms22136767.
Molecular profiling of appendiceal serrated lesions, polyps and mucinous neoplasms: a single-centre experience.
Munari G, Businello G, Mattiolo P, Pennelli G, Sbaraglia M, Borga C
J Cancer Res Clin Oncol. 2021; 147(7):1897-1904.
PMID: 33712927
PMC: 8164605.
DOI: 10.1007/s00432-021-03589-4.
Neoadjuvant chemoradiation alters biomarkers of anticancer immunotherapy responses in locally advanced rectal cancer.
Seo I, Lee H, Byun S, Park J, Min H, Lee S
J Immunother Cancer. 2021; 9(3).
PMID: 33692216
PMC: 7949478.
DOI: 10.1136/jitc-2020-001610.
The Role of the Pathologist in the Next-Generation Era of Tumor Molecular Characterization.
Angerilli V, Galuppini F, Pagni F, Fusco N, Malapelle U, Fassan M
Diagnostics (Basel). 2021; 11(2).
PMID: 33670699
PMC: 7922586.
DOI: 10.3390/diagnostics11020339.
Whole-exome sequencing identified a novel mutation of in an extended family with lynch syndrome.
Ghaedi H, Ramsheh S, Omidvar M, Labbaf A, Alehabib E, Akbari S
Genes Dis. 2020; 7(4):614-619.
PMID: 33335961
PMC: 7729095.
DOI: 10.1016/j.gendis.2019.07.011.
Current prognostic and predictive biomarkers for gastrointestinal tumors in clinical practice.
Fassan M, Scarpa A, Remo A, De Maglio G, Troncone G, Marchetti A
Pathologica. 2020; 112(3):248-259.
PMID: 33179625
PMC: 7931577.
DOI: 10.32074/1591-951X-158.
Clinical Significance of Tumor and Immune Cell PD-L1 Expression in Gastric Adenocarcinoma.
Kim D, Bae G, Suh K, Ryuman D, Song K, Kim J
In Vivo. 2020; 34(6):3171-3180.
PMID: 33144421
PMC: 7811673.
DOI: 10.21873/invivo.12152.
Impact of Pre-Analytical Factors on MSI Test Accuracy in Mucinous Colorectal Adenocarcinoma: A Multi-Assay Concordance Study.
Malapelle U, Parente P, Pepe F, De Luca C, Cerino P, Covelli C
Cells. 2020; 9(9).
PMID: 32887373
PMC: 7565496.
DOI: 10.3390/cells9092019.
Questioning the IGF1 receptor's assigned role in CRC - a case for rehabilitation?.
Heckl S, Pellinghaus M, Behrens H, Kruger S, Schreiber S, Rocken C
BMC Cancer. 2020; 20(1):704.
PMID: 32727431
PMC: 7391533.
DOI: 10.1186/s12885-020-07173-w.
Diagnostic management of occult nodal lymphangioleiomyomatosis detected during pelvic cancer staging. Localized finding or systemic disease?.
Remo A, Zanella C, Parcesepe P, Greco F, Pancione M, Zapparoli M
Sarcoidosis Vasc Diffuse Lung Dis. 2020; 36(1):33-38.
PMID: 32476934
PMC: 7247108.
DOI: 10.36141/svdld.v36i1.7110.
Prediction of Benefit from Checkpoint Inhibitors in Mismatch Repair Deficient Metastatic Colorectal Cancer: Role of Tumor Infiltrating Lymphocytes.
Loupakis F, Depetris I, Biason P, Intini R, Prete A, Leone F
Oncologist. 2020; 25(6):481-487.
PMID: 31967692
PMC: 7288636.
DOI: 10.1634/theoncologist.2019-0611.
Treatment with checkpoint inhibitors in a metastatic colorectal cancer patient with molecular and immunohistochemical heterogeneity in MSI/dMMR status.
Loupakis F, Maddalena G, Depetris I, Murgioni S, Bergamo F, Dei Tos A
J Immunother Cancer. 2019; 7(1):297.
PMID: 31703605
PMC: 6842181.
DOI: 10.1186/s40425-019-0788-5.
CK7 and consensus molecular subtypes as major prognosticators in BRAF mutated metastatic colorectal cancer.
Loupakis F, Biason P, Prete A, Cremolini C, Pietrantonio F, Pella N
Br J Cancer. 2019; 121(7):593-599.
PMID: 31474758
PMC: 6889398.
DOI: 10.1038/s41416-019-0560-0.